[go: up one dir, main page]

RU2017143184A3 - - Google Patents

Download PDF

Info

Publication number
RU2017143184A3
RU2017143184A3 RU2017143184A RU2017143184A RU2017143184A3 RU 2017143184 A3 RU2017143184 A3 RU 2017143184A3 RU 2017143184 A RU2017143184 A RU 2017143184A RU 2017143184 A RU2017143184 A RU 2017143184A RU 2017143184 A3 RU2017143184 A3 RU 2017143184A3
Authority
RU
Russia
Application number
RU2017143184A
Other languages
Russian (ru)
Other versions
RU2695062C2 (en
RU2017143184A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017143184A publication Critical patent/RU2017143184A/en
Publication of RU2017143184A3 publication Critical patent/RU2017143184A3/ru
Application granted granted Critical
Publication of RU2695062C2 publication Critical patent/RU2695062C2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2017143184A 2015-05-22 2015-05-22 Novel 3,5-divinyl-pyrazole derivatives for medical use RU2695062C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2015/000323 WO2016190770A1 (en) 2015-05-22 2015-05-22 Novel derivatives of 3,5-divinyl-pyrazole for medical application

Publications (3)

Publication Number Publication Date
RU2017143184A RU2017143184A (en) 2019-06-24
RU2017143184A3 true RU2017143184A3 (en) 2019-06-24
RU2695062C2 RU2695062C2 (en) 2019-07-19

Family

ID=57392950

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017143184A RU2695062C2 (en) 2015-05-22 2015-05-22 Novel 3,5-divinyl-pyrazole derivatives for medical use

Country Status (2)

Country Link
RU (1) RU2695062C2 (en)
WO (1) WO2016190770A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7244987B2 (en) * 2016-12-14 2023-03-23 シージェン インコーポレイテッド Multidrug Antibody Drug Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002314566A1 (en) * 2002-06-17 2003-12-31 Ho-Jeong Kwon Novel curcumin derivatives
CA2832650C (en) * 2011-04-11 2019-05-07 Pharma Eight Co. Ltd. Pyrazole derivative

Also Published As

Publication number Publication date
WO2016190770A1 (en) 2016-12-01
RU2695062C2 (en) 2019-07-19
RU2017143184A (en) 2019-06-24

Similar Documents

Publication Publication Date Title
BR112017026777A2 (en)
BR112018002739A2 (en)
BR112018004316A2 (en)
RU2017143184A3 (en)
BR122019018962A2 (en)
BR0002402B1 (en)
BR0008874B1 (en)
CN303072178S (en)
BR9801568B1 (en)
BR8302297Y1 (en)
BR0209741B1 (en)
BR0114791B1 (en)
BR0017632B1 (en)
BR0009994B1 (en)
BR0009942B1 (en)
BR0009761B1 (en)
BR0009757B1 (en)
BR0009717B1 (en)
BR0007672B1 (en)
BR0009182B1 (en)
BR0007688B1 (en)
BR0008789B1 (en)
BR0008719B1 (en)
BR0008604B1 (en)
BR0009349B1 (en)

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20200523